| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alx Oncology Holdings Inc (ALXO) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 35 sells. ALXO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 305.9K | $468.1K | - | |
| CFO | 303.0K | $463.6K | - | |
| Dir | 300.0K | $459.0K | - | |
| VP | 192.0K | $293.8K | - | |
| 10% | 40.4K | $61.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2021 | Randolph Sophia88 | Chief Medical Officer | Sell | 7,387 | $54.90 | $405,527.15 | -2.1% | +11.8% | -81.5% | |
| Jun 21, 2021 | Pons Jaume89 | President &CEO | Sell | 16,700 | $58.59 | $978,480.26 | -1.6% | +25.7% | -88.6% | |
| Jun 10, 2021 | Randolph Sophia88 | Chief Medical Officer | Sell | 7,387 | $60.88 | $449,696.81 | -1.3% | +21.1% | -88.9% | |
| May 19, 2021 | Pons Jaume89 | President &CEO | Sell | 16,700 | $55.71 | $930,276.00 | -1.0% | +23.3% | -84.2% | |
| May 10, 2021 | Randolph Sophia88 | Chief Medical Officer | Sell | 7,387 | $61.97 | $457,771.58 | -1.0% | +5.8% | -84.1% | |
| Apr 19, 2021 | Pons Jaume89 | President &CEO | Sell | 16,700 | $57.63 | $962,433.39 | -0.6% | -2.5% | -72.4% | |
| Apr 12, 2021 | Randolph Sophia88 | Chief Medical Officer | Sell | 7,387 | $59.43 | $438,977.74 | -0.8% | -5.5% | -70.3% | |
| Mar 22, 2021 | Pons Jaume89 | President And CEO | Sale+OE | 16,700 | $68.49 | $1,143,860.49 | -0.4% | -15.5% | -73.0% | |
| Mar 10, 2021 | Randolph Sophia88 | Chief Medical Officer | Sell | 7,387 | $74.34 | $549,173.18 | -0.9% | -20.7% | -74.9% | |
| Dec 14, 2020 | Graham G. Walmsley48 | Director | Buy | 20,000 | $76.00 | $1,520,000.00 | +2.1% | - | - |